Tag

Medicare Advantage

All articles tagged with #medicare advantage

market-news1 month ago•17 min saved

Morgan Stanley Upgrades UNH Ahead of Earnings on Margin and AI Upside

Morgan Stanley upgrades UnitedHealth (UNH) to Top Pick ahead of its Q1 results, citing clearer Medicare Advantage rate guidance, ongoing MA margin improvement, an Optum Health turnaround, and potential AI-driven efficiencies. A Q1 miss or beat is expected to be largely in line with expectations, with analysts eyeing tangible margin gains in 2027–2028 and a stronger stock trajectory if results align. The firm’s price target is $375 amid a broader Street consensus of Strong Buy with roughly 13% 12‑month upside.

via TipRanks|

#earnings #market-news #medicare-advantage

health1 month ago•258 min saved

Medicare Advantage gets a $13B boost for 2027, easing costs for seniors

CMS approved a 2.48% funding uplift for 2027, adding over $13 billion to Medicare Advantage plans and giving insurers more room to hold premiums and maintain extra benefits like dental and vision; while overall health-care costs won't drop dramatically, the change could ease out-of-pocket costs for many seniors, making coverage more stable—so review plans during open enrollment.

via AOL.com|

#health #healthcare-costs #medicare-advantage

healthcare2 months ago•4 min saved

Aetna Pays $117.7 Million to Resolve Medicare Advantage Coding Allegations

Aetna will pay $117.7 million to settle False Claims Act allegations that it submitted or failed to withdraw inaccurate diagnosis codes to inflate Medicare Advantage payments, including morbid obesity codes for 2018–2023, and related issues from a 2015 chart-review program; a whistleblower, a former Aetna risk-adjustment coder, will receive about $2.01 million. The case was pursued by the DOJ Civil Division, Fraud Section, and HHS-OIG with the U.S. Attorney’s Office for the Eastern District of Pennsylvania.

via Department of Justice (.gov)|

#aetna #false-claims-act #healthcare

politics3 months ago•9 min saved

Trump’s 2027 Medicare Advantage bump signals austerity for private plans

The Trump administration proposes a 2027 pay increase for Medicare Advantage of less than 1% (about $700 million), a smaller boost than insurers hoped and aimed at stabilizing payments while curbing upcoding. Insurers warn the modest increase could force benefit cuts or higher seniors’ premiums, while CMS argues the measure is a right-sizing effort to reduce waste; a final rate decision in spring will trigger renewed lobbying from industry and policymakers.

via Politico|

#cms #medicare-advantage #medicare-payments

markets4 months ago•19 min saved

UnitedHealth slumps 20% on 2026 revenue decline outlook and Medicare-rate surprise

UnitedHealth Group dropped about 20% after it forecast a at-least-2% revenue decline for 2026 and issued a subdued earnings outlook (EPS at least $17.75, medical-care ratio ~88.8%), while a smaller-than-expected Medicare Advantage rate increase and ongoing investigations added to investor concern.

via MarketWatch|

#earnings #markets #medicare-advantage

business4 months ago•2 min saved

UNH: Margin Pressure Now, AI-Driven Efficiency to Drive Long-Term Upside

UnitedHealth Group remains a contrarian buy after a selloff driven by Medicare Advantage margin concerns; 2026 revenue is expected to fall about 2% while operating income tops $24 billion due to cost controls and AI-led efficiency gains. Near-term EPS growth is about 8.6%, but management targets a long-term adjusted EPS CAGR of 13–16%, suggesting meaningful upside if multiple expands to a forward P/E around 15.8. With strong cash flow funding dividends, buybacks, and roughly $1.5 billion a year in tech/AI investments, the key risks are medical cost volatility and ongoing Medicare funding pressures.

via Seeking Alpha|

#ai-cost-controls #business #earnings-guidance

business4 months ago•7 min saved

Medicare Rate Surprise Triggers Selloff in Major Health-Insurers

The CMS proposed only a 0.09% average 2027 increase for Medicare Advantage rates, far below analysts’ expectations, sending shares of UnitedHealth, Humana, CVS Health and peers down sharply (as much as about 20% for UNH) on concerns about margins and future revenue. The notice also highlighted a plan to exclude diagnosis information from certain risk-score calculations, which could further affect payments. Analysts noted the flat-rate stance would blunt the sector’s margin turnaround despite past rate hikes, contributing to a broad market pullback in health-insurer stocks.

via Barron's|

#business #earnings #health-insurance

business4 months ago•2 min saved

UnitedHealth Struggles With Earnings Miss And Margin Headwinds

UnitedHealth reported a Q4 revenue and EPS miss with its medical care ratio at 89.1%, signaling ongoing margin pressure. Medicare Advantage reimbursement increases are expected to be modest, adding near-term headwinds and tempering the earnings outlook. Management suggests 2026 will be a transition year, offering potential long-term upside for patient investors while the near term remains challenging.

via Seeking Alpha|

#business #earnings-miss #margin-pressure

business4 months ago•4 min saved

Markets Hold Steady Ahead of Fed Decision as Earnings Week Kicks Into Gear

Futures for the S&P 500 were largely unchanged as traders await the Fed’s rate decision this week; after Monday’s gains led by tech, health insurers fell in after-hours trading on CMS’s near-flat Medicare Advantage payment proposal for 2027, while President Trump signaled higher tariffs on South Korean autos, pharmaceuticals and lumber, adding risk to an earnings-heavy week.

via CNBC|

#business #earnings #fed

markets4 months ago•14 min saved

Bernstein names UnitedHealth as 2026's top healthcare pick

Bernstein analyst Lance Wilkes designates UnitedHealth Group (UNH) as his top healthcare stock for 2026, keeping an Outperform rating with a $444 target as margins in Medicare Advantage/Medicaid are expected to recover. He expects earnings growth to resume as UNH exits unprofitable businesses and weighs the potential separation of UnitedHealthcare and Optum, with Optum viewed as a long‑term growth driver. Bernstein sees roughly 33% upside from current levels, while the broader market consensus remains bullish with a target near $398 (~19% upside).

via TipRanks|

#bernstein #markets #medicare-advantage

business4 months ago•3 min saved

Kaiser Permanente to pay $556 million to settle Medicare Advantage fraud allegations

The Justice Department announced a $556 million settlement with Kaiser Permanente over allegations that it inflated Medicare Advantage payments by adding improper diagnoses to patient charts after visits, a practice the government says diverted about $1 billion from taxpayers between 2009 and 2018; Kaiser says the settlement resolves the matter without admitting wrongdoing and notes it concerns risk-adjustment practices rather than care quality.

via statnews.com|

#business #doj-settlement #healthcare-fraud

business4 months ago•1 min saved

Kaiser Permanente Settles Medicare Billing Dispute for $556 Million

Kaiser Permanente agreed to pay $556 million to settle civil lawsuits accusing it of inflating patient illness levels to boost Medicare Advantage payments; the DOJ and whistleblowers alleged up to $1 billion in overbilling, with the deal setting a record Medicare Advantage settlement.

via The New York Times|

#business #kaiser-permanente #medicare-advantage

politics4 months ago•7 min saved

Grassley accuses UnitedHealth of turning Medicare Advantage risk scoring into a profit engine

A Senate majority staff report based on more than 50,000 pages alleges UnitedHealth Group uses aggressive diagnosis capture, in-home health risk assessments, and coding guidance to inflate Medicare Advantage risk scores and in turn receive higher CMS payments. The findings describe a specialized workforce and data capabilities that adapt to CMS crackdowns, with examples like diagnoses for opioid dependence, alcohol use disorders, and dementia, and warn that the company sells its criteria to other MAOs, potentially impacting taxpayers and the integrity of the MA program. The report follows Grassley’s long history of MA oversight and calls for continued scrutiny of risk-adjustment practices.

via Grassley.senate.gov|

#cms #grassley #medicare-advantage

healthcare4 months ago•1 min saved

Medicare Advantage to Drop Coverage for Certain Items in 2026

Starting in 2026, Medicare Advantage plans will no longer cover certain items due to new CMS restrictions, marking a change from the expanded coverage seen in 2018.

via The Motley Fool|

#2026 #cms #coverage-restrictions

healthcare6 months ago•4 min saved

Medicare Open Enrollment: Key Updates for Federal Employees and State Residents

Dave Ramsey emphasizes that the Medicare Annual Enrollment Period (AEP) is for current beneficiaries to modify their coverage, not for first-time enrollees, who should sign up at age 65. He explains the differences between Original Medicare and Medicare Advantage, and highlights upcoming changes in 2026, including a cap on out-of-pocket drug costs at $2,100.

via TheStreet|

#2026-drug-costs #aep #healthcare